Alteogen-powered Keytruda SC expands bladder cancer indication in Europe
Predicted impact: Low
Keytruda SC indication expansion is a partner's approval news; no revenue size disclosed.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.